Merck Animal Health to Acquire Elanco’s Aqua Business
The aquisition complements Merck Animal Health’s broad portfolio of veterinary pharmaceuticals, vaccines and technology solutions.
(UNITED STATES, 2/5/2024)
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), has announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN) for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species; two related aqua manufacturing facilities in Canada and Vietnam; as well as a research facility in Chile. The acquisition is expected to be completed by mid-year 2024, subject to approvals from regulatory authorities and other customary closing co...
(More Info)
Ayelén dreams of an all-female shrimping crew Argentina
Ayelén Lecumbarry, who comes from a long line of fishermen in Rawson, Chubut, is the one behind this innovative proposal
Ayelén has submitted a study she designed herself to obtain the ...
Healthy Fish Stocks Drive Increased Fishing Quotas for 2025 Denmark
Danish fisheries are set for a promising 2025, with increased quotas for several key fish stocks in the North Sea and Skagerrak. This positive outlook follows the signing of four pivotal fisheries agr...
Soaring Shrimp Demand in Southern Europe, stable in other regions Viet Nam
As of November 15, 2024, Vietnam’s shrimp exports to the EU reached over $422 million, marking a 16% increase compared to the same period last year.
The EU market has shown consistent demand for ...
Copyright 1995 - 2024 Seafood Media Group Ltd.| All Rights Reserved. DISCLAIMER
Merck Animal Health (former Intervet Inc)
(UNITED STATES, 2/5/2024)
